Procaps Group, S.A Total Non-Operating Income/Expense 2020-2023 | PROCF
Procaps Group, S.A total non-operating income/expense from 2020 to 2023. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Procaps Group, S.A Annual Total Non-Operating Income/Expense (Millions of US $) |
2022 |
$13 |
2021 |
$-158 |
2020 |
$-62 |
2020 |
$-12 |
2019 |
$-47 |
2019 |
$ |
2018 |
$ |
Procaps Group, S.A Quarterly Total Non-Operating Income/Expense (Millions of US $) |
2023-09-30 |
$-2 |
2023-06-30 |
$23 |
2023-03-31 |
$6 |
2022-12-31 |
$7 |
2022-09-30 |
$13 |
2022-06-30 |
$-27 |
2022-03-31 |
$20 |
2021-12-31 |
$-1 |
2021-09-30 |
$-126 |
2021-06-30 |
$-16 |
2021-03-31 |
$-15 |
2020-12-31 |
$-6 |
2020-09-30 |
$-16 |
2020-06-30 |
$-4 |
2020-03-31 |
$3 |
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|